Skip to main
AMRZ

Amrize Ltd (AMRZ) Stock Forecast & Price Target

Amrize Ltd (AMRZ) Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 13%
Buy 50%
Hold 38%
Sell 0%
Strong Sell 0%

Bulls say

Amrize is expected to benefit from the recovery of the private construction sector in the US, strong pricing in both building materials and building envelope segments, and the recent acquisition of PB Materials at a 12x EBITDA multiple. There are also potential upsides from infrastructure funding, strong volume growth, and efficient supply chain management. However, potential downside risks include weak pricing and mix shift in the building envelope segment, as well as the cyclical nature of the heavy building materials market. As Amrize's business is heavily reliant on the North American market, any slowdown in the US economy could also impact its financial performance.

Bears say

Amrize is operationally headquartered in Chicago,IL and operates through two segments: Building Materials and Building Envelope. The BuildingMaterials Solutions segment includes cement,aggregates, ready-mix concrete, and asphalt. TheBuilding Envelope segment includes commercial andresidential roofing and wall solutions. AMRZ is thelargest producer of cement in North America.

Amrize Ltd (AMRZ) has been analyzed by 8 analysts, with a consensus rating of Buy. 13% of analysts recommend a Strong Buy, 50% recommend Buy, 38% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Amrize Ltd and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Amrize Ltd (AMRZ) Forecast

Analysts have given Amrize Ltd (AMRZ) a Buy based on their latest research and market trends.

According to 8 analysts, Amrize Ltd (AMRZ) has a Buy consensus rating as of Jul 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $61.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $61.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Amrize Ltd (AMRZ)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.